Week of April 25, 2022 | Vol. 11, Issue 17
Events Hosted or Attended by Bourne Partners
April 23-26, 2022 - Palm Beach, FL
May 17-19, 2022 - Philadelphia, PA
May 24-26, 2022 - New York City, NY
June 13-16, 2022 - San Diego, CA
June 19-23, 2022 - Chicago IL
August 27-29, 2022 - Boston, MA
October 2022 - Charlotte, NC
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table. 

Note: data reflects prior week close.
Insight Into Healthcare Related Industries
Representative Current Retained Sell-Side And Partnering Opportunities
Project Gateway
Sell-side | Pharma | Generic pharmaceuticals

Project Nucleus
Buy-side| CDMO | North American radiopharmaceutical company

Project Panther
[Buy/sell]-side| [Pharma, CDMO, Generic Pharma, etc.] | [What the company does]
Project Power Play
Buy-side | Specialty Pharma | In-license and acquire approved Rx products including legacy brands, generics, and niche launch-ready products

Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics
A Sampling of Industry Headlines From Last Week
Regeneron plans to show there is more to skin cancer than PD-1 inhibitors through the $250 million acquisition of Checkmate Pharmaceuticals for the lead immuno-oncology asset vidutolimod.
As weeks turn into months, the war in Ukraine has prompted a mass exodus of businesses and consumer brands from Russia.
Data-driven therapeutics company Octant Bio is exploring new frontiers of drug development with $80 million in-pocket and a freshly signed Big Pharma partnership.
Like a young joey carried safely in a marsupial's pouch, so too will devicemaker Phenox be tucked into its new parent company, the aptly named Wallaby Medical.

TannerMAP works across the broad spectrum of pharma services, creating opportunities that benefit manufacturers and patients alike. Learn more about the division from industry veterans and Tanner EVPs, Rob Keel and John Lagus.

Tanner Pharma announced last week its expansion to Ireland with the opening of a new office space in Cork, the country’s third largest city. The new location was selected after many months of travel and research by Tanner’s executive team.

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.